Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Crypto Market Update: UK Backs “No Gain, No Loss” Tax Model, Visa Expands Stablecoin Settlement November 29, 2025 Canada-Alberta Pact: Boosting Oil Exports and Clean Energy November 29, 2025 Barrick Closes US$1.09 Billion Hemlo Sale as Wheaton Finalizes Gold Stream Deal November 29, 2025
Crypto Market Update: UK Backs “No Gain, No Loss” Tax Model, Visa Expands Stablecoin Settlement November 29, 2025